PreDiagnose ApS: Financial statements 2023
CVR: 38562770
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PreDiagnose ApS (CVR 38562770) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 52,969 and a net result of DKK 40,403 compared with DKK -63,890 the year before. That is a decrease of 37.7% compared with the year before. Equity in the 2023 report amounted to DKK 1,140,863. The solvency ratio was 80.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 52,969
- Profit/Loss
- DKK 40,403
- Equity
- DKK 1,140,863
- Total Assets
- DKK 1,424,352
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 53 t. | 40 t. | 1.1 mio. | 1 |
| 2022 | - | 85 t. | -64 t. | 1.1 mio. | 1 |
| 2021 | - | 574 t. | 453 t. | 1.2 mio. | 3 |
| 2020 | - | 766 t. | 628 t. | 712 t. | 3 |
| 2019 | - | 109 t. | 82 t. | 83 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PreDiagnose ApS has published its annual report for 2022. Gross profit came to DKK 85,026, and the net result was DKK -63,890.
About PreDiagnose ApS
PreDiagnose ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PreDiagnose IVS. The management consists of Fatima Al-Zahraa Al Atraktchi. The company is owned by FZA ApS. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK 129,206 and a net result of DKK 2,564 compared with DKK 60,353 the year before. Equity in the 2025 report amounted to DKK 1,203,779.